Alector (ALEC) Operating Leases (2019 - 2026)
Alector (ALEC) reported Operating Leases of $15.6 million for Q1 2026, down 31.24% year-over-year from $22.8 million in Q1 2025, and down 10.53% quarter-over-quarter from $17.5 million in Q4 2025.
Alector (ALEC) Operating Leases (2019 - 2026) Analysis & Trends
Alector (ALEC) has 8 years of Operating Leases data on file, last reported at $15.6 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $15.6 million, down 31.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.6 million (down 31.24% YoY), and the FY2025 annual result was $17.5 million, down 28.26% from the prior year.
- Operating Leases eased to $15.6 million in Q1 2026 per ALEC's latest filing, from $17.5 million in the prior quarter.
- Over five years, Operating Leases peaked at $38.8 million in Q1 2022 and troughed at $15.6 million in Q1 2026.
- A 5-year average of $28.3 million and a median of $29.0 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2026: Operating Leases retreated 9.51% in 2022, then slumped 31.24% in 2026.
- A 5-year view of Operating Leases shows it stood at $35.3 million in 2022, then decreased by 13.64% to $30.5 million in 2023, then dropped by 19.96% to $24.4 million in 2024, then declined by 28.26% to $17.5 million in 2025, then dropped by 10.53% to $15.6 million in 2026.
- Business Quant data shows ALEC's Operating Leases at $15.6 million in Q1 2026, $17.5 million in Q4 2025, and $19.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.65 Mn |
| Dec 31, 2025 | 17.49 Mn |
| Sep 30, 2025 | 19.29 Mn |
| Jun 30, 2025 | 21.04 Mn |
| Mar 31, 2025 | 22.75 Mn |
| Dec 31, 2024 | 24.38 Mn |
| Sep 30, 2024 | 25.96 Mn |
| Jun 30, 2024 | 27.51 Mn |
| Mar 31, 2024 | 29.02 Mn |
| Dec 31, 2023 | 30.46 Mn |
| Sep 30, 2023 | 31.84 Mn |
| Jun 30, 2023 | 32.75 Mn |
| Mar 31, 2023 | 34.05 Mn |
| Dec 31, 2022 | 35.27 Mn |
| Sep 30, 2022 | 36.46 Mn |
| Jun 30, 2022 | 37.62 Mn |
| Mar 31, 2022 | 38.75 Mn |
| Dec 31, 2021 | 39.81 Mn |
| Sep 30, 2021 | 40.83 Mn |
| Jun 30, 2021 | 41.84 Mn |